COVID-19 infection in a patient with Cushing's disease on osilodrostat treatment

Endokrynol Pol. 2023;74(3):342-343. doi: 10.5603/EP.a2023.0041. Epub 2023 Jun 19.

Abstract

Not required for Clinical Vignette.

Keywords: COVID-19; Cushing’s disease; osilodrostat.

MeSH terms

  • COVID-19* / complications
  • Humans
  • Imidazoles
  • Pituitary ACTH Hypersecretion* / complications
  • Pituitary ACTH Hypersecretion* / drug therapy
  • Pyridines

Substances

  • Osilodrostat
  • Imidazoles
  • Pyridines